Mirador

Developer of therapeutics for immune-mediated inflammatory and fibrotic diseases

placeSan Diego, California, United States calendar_todayFounded 2023 language miradortx.com

Social engagement

Social engagement: 119 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

20 investors on record; lead investors include Arch Venture Partners.

Investor typeCountShare
Venture capital945%
Private equity210%
Bank & private debt315%
Other / undisclosed630%
Coming soon